Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
GSK Reports Sustained Efficacy of RSV Vaccine Amidst Competition from Pfizer and Moderna
11:31am, Tuesday, 08'th Oct 2024
GSK (GSK, Financial) announced that its respiratory syncytial virus (RSV) vaccine has shown protective benefits for three quarters following vaccination. The cumulative efficacy of the vaccine, adjust
Pfizer CEO's Job Is at Risk. A Shot of Discipline Could Help.
09:00am, Tuesday, 08'th Oct 2024
As activist Starboard teams up with former Pfizer executives, the pharma giant's lack of focus is in the spotlight.
Watch These Pfizer Price Levels as Stock Gains After Report of Starboard Taking Stake
08:35am, Tuesday, 08'th Oct 2024
Pfizer (PFE) shares have gained ground since theThe Wall Street Journal reported over the weekend that activist investor Starboard Value has taken a roughly $1 billion stake in the drug maker and is p
Pfizer: A 6% Yielding Ultra SWAN Bargain With Upside Potential
07:00am, Tuesday, 08'th Oct 2024
Pfizer, yielding 5.6%, is an Ultra SWAN bargain with upside potential in the next year. Despite $70 billion in debt, Pfizer's A- credit rating and stable cash flow ensure long-term stability and very
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
06:50am, Tuesday, 08'th Oct 2024
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and said it was a once-in-a-lifetime shot for now, excluding millions of people w
Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents
05:50am, Tuesday, 08'th Oct 2024
Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's High Court.
Zacks Industry Outlook Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer
05:05am, Tuesday, 08'th Oct 2024
Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer have been highlighted in this Industry Outlook article.
Pfizer: A Strong Product Pipeline Could Lead To Significant Upside
04:52am, Tuesday, 08'th Oct 2024
Pfizer's stock has likely bottomed and shows strong technical and fundamental indicators, including a "Golden Cross" and robust cost reduction plans. The company's promising pipeline, including weight
Why Pfizer Will Find It Hard to Appease Its Activist Investor
12:04am, Tuesday, 08'th Oct 2024
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
Meet Jeff Smith, the hedge-fund investor taking on Pfizer
07:11pm, Monday, 07'th Oct 2024
Starboard Value has taken a $1 billion stake in drugmaker Pfizer. The hedge fund, headed by Jeff Smith, has become one of the most feared activist investors.
Pfizer needs to 'fix what they have', no M&A capacity, says BMO's Evan Seigerman on activist stake
05:39pm, Monday, 07'th Oct 2024
Evan David Seigerman, BMO Biotech Analyst, joins 'Closing Bell Overtime' to talk Pfizer shares climbing on activist firm Starboard taking a stake in the company.
Chart of the Day: Pfizer
01:22pm, Monday, 07'th Oct 2024
Starboard takes a $1 billion stake in $PFE. It's our Chart Of The Day.
Starboard Value takes up $1 billion stake in Pfizer: WSJ
12:56pm, Monday, 07'th Oct 2024
Pharmaceutical giant Pfizer (PFE) is seeing stock gains in Monday's pre-market trading after activist investor Starboard Value took up a $1 billion stake, according to a Wall Street Journal report. Ya
Pfizer (PFE) Surges on Starboard's $1 Billion Investment Plan
12:26pm, Monday, 07'th Oct 2024
Pfizer (PFE, Financial) stock saw a notable increase of 2.94% attributed to a reported $1 billion investment by activist investor Starboard Value. This strategic move is intended to breathe new life i
Why Pfizer Stock Popped on Monday
12:18pm, Monday, 07'th Oct 2024
Can Starboard Value and former CEO Ian Read save Pfizer stock?
